A class label covering single, dual and triple receptor agonists. Here is what separates them, and their status in Australia.
GLP-1 receptor agonist is a class label covering molecules described as acting at the
glucagon-like peptide-1 receptor. Members of the class differ in how many receptors they are
described as targeting.
An important distinction. Some compounds in this class are registered
prescription medicines in Australia. Evra does not supply medicines. We supply research-grade
material for laboratory use only, and nothing here is an offer of a therapeutic good. If you
are looking for a prescription medicine, speak to a doctor or pharmacist.
Single, dual and triple
The main structural distinction within the class is how many receptor targets a molecule is
described as acting on in the literature.
Semaglutide and tirzepatide are registered prescription medicines under
brand names. They are only lawfully supplied for human use on prescription, by a pharmacist.
Retatrutide is an investigational compound and is not approved as a
medicine anywhere.
Everything Evra supplies is research-grade material for laboratory use, not for human
consumption, and is not supplied as a medicine regardless of a compound's status elsewhere.
Common questions
What is a GLP-1 receptor agonist?
A compound described as acting at the glucagon-like peptide-1 receptor. The class has been studied extensively in metabolic research.
What does single, dual and triple agonist mean?
How many receptor targets a molecule is described as acting on. Semaglutide is described as a GLP-1 agonist; tirzepatide as a dual GIP/GLP-1 agonist; retatrutide as a triple GLP-1/GIP/glucagon agonist.
Are these prescription medicines in Australia?
Semaglutide and tirzepatide are registered prescription medicines in Australia under brand names. Evra does not supply medicines, we supply research-grade material for laboratory use only. Anyone seeking a prescription medicine should speak to a doctor or pharmacist.
Is retatrutide approved?
No. Retatrutide is an investigational compound and is not approved as a medicine in Australia or elsewhere. It is supplied strictly for laboratory research.
Still stuck?
Message the team on Telegram and we will sort it out, usually within minutes.
For research use only. This page describes what these compounds are and what published research has investigated. It does not recommend one over another, does not describe any effect in humans, and is not medical advice or a dosing recommendation. Evra Peptides products are supplied strictly for laboratory research and are not for human or veterinary consumption, nor for diagnostic or therapeutic use. You must be 18 or over to order.